urapidil has been researched along with Coronary Disease in 6 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "20 patients who developed arterial hypertension following coronary artery bypass grafting were randomly treated with either sodium nitroprusside (SNP) or urapidil." | 9.06 | [The effect of urapidil and sodium nitroprusside on intrapulmonary right-left shunt and arterial oxygenation in the treatment of hypertension following coronary surgery]. ( Lauwers, P; Möllhoff, T; Mulier, JP; Müller, E; van Aken, H, 1989) |
| "20 patients who developed arterial hypertension following coronary artery bypass grafting were randomly treated with either sodium nitroprusside (SNP) or urapidil." | 5.06 | [The effect of urapidil and sodium nitroprusside on intrapulmonary right-left shunt and arterial oxygenation in the treatment of hypertension following coronary surgery]. ( Lauwers, P; Möllhoff, T; Mulier, JP; Müller, E; van Aken, H, 1989) |
| "Urapidil was a much weaker coronary vasodilator than dipyridamole." | 1.29 | Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion. ( Deruyter, HA; Flameng, W; Marcus, MA; Mignolet, K; Miserez, M; Van Aken, HK; van de Velde, M; Wouters, PF, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gregorini, L | 1 |
| Marco, J | 1 |
| Farah, B | 1 |
| Bernies, M | 1 |
| Palombo, C | 1 |
| Kozàkovà, M | 1 |
| Bossi, IM | 1 |
| Cassagneau, B | 1 |
| Fajadet, J | 1 |
| Di Mario, C | 1 |
| Albiero, R | 1 |
| Cugno, M | 1 |
| Grossi, A | 1 |
| Heusch, G | 1 |
| Zähringer, J | 1 |
| Klepzig, M | 1 |
| Greif, J | 1 |
| Ludwig, B | 1 |
| Strauer, B | 1 |
| Wouters, PF | 1 |
| Marcus, MA | 1 |
| Van Aken, HK | 1 |
| van de Velde, M | 1 |
| Miserez, M | 1 |
| Deruyter, HA | 1 |
| Mignolet, K | 1 |
| Flameng, W | 1 |
| Vergroesen, I | 1 |
| Kal, JE | 1 |
| Spaan, JA | 1 |
| Van Wezel, HB | 1 |
| Schad, H | 1 |
| Heimisch, W | 1 |
| Barankay, A | 1 |
| Hesse, S | 1 |
| Mendler, N | 1 |
| Möllhoff, T | 1 |
| Mulier, JP | 1 |
| Müller, E | 1 |
| van Aken, H | 1 |
| Lauwers, P | 1 |
3 trials available for urapidil and Coronary Disease
| Article | Year |
|---|---|
Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrener | 2002 |
Myocardial oxygen supply:demand ratio as reference for coronary vasodilatory drug effects in humans.
Topics: Aged; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Artery Bypass; Coronary Circulat | 1997 |
[The effect of urapidil and sodium nitroprusside on intrapulmonary right-left shunt and arterial oxygenation in the treatment of hypertension following coronary surgery].
Topics: Antihypertensive Agents; Coronary Artery Bypass; Coronary Disease; Ferricyanides; Hemodynamics; Huma | 1989 |
3 other studies available for urapidil and Coronary Disease
| Article | Year |
|---|---|
[Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease].
Topics: Acute Disease; Antihypertensive Agents; Coronary Disease; Echocardiography; Female; Hemodynamics; Hu | 1984 |
Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
Topics: Adrenergic alpha-Antagonists; Animals; Atrial Function, Left; Blood Pressure; Chronic Disease; Colla | 1994 |
Effect of urapidil on the performance of ischaemic myocardium in anaesthetized dogs.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Coronary Disease; Dogs; Dose-Respons | 1989 |